Matthew L. Posard, Director: Halozyme Therapeutics HALO Sell · Filed 24/06/13

Trade details

Type: Insider sale
Amount: $500,100
Shares · price: 10,000 sh · $50.01 a share
Held after: 109,755 sh
Stock: Halozyme Therapeutics HALO
Person: Matthew L. PosardDirector
Trade date: 24/06/11
Filed: 24/06/13
Days to filing: 2 days

Sold 8.4% of holdings

Share of holding sold: 8.4%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/12~24/07/11

Matthew L. Posard's recent trades

Matthew L. PosardDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$3.6M
34,226 sh
$3.6M
Filed 09/16
Traded 09/16
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$570.1K
9,881 sh
$570.1K
Filed 24/08/14
Traded 24/08/14
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$561.9K
10,000 sh
$561.9K
Filed 24/08/14
Traded 24/08/13
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$557.2K
10,000 sh
$557.2K
Filed 24/08/14
Traded 24/08/12
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$506.2K
10,000 sh
$506.2K
Filed 24/06/13
Traded 24/06/12